Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy
- Status
- RECRUITING
- Phase
- N/A
Surgery of Melanoma Metastases After Systemic Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
TNFalpha and Interleukin 2 Coding Oncolytic Adenovirus TILT-123 During TIL Treatment of Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Immune Monitoring in Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- N/A
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
CD24Fc With Ipilimumab and Nivolumab to Decrease irAE (CINDI)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
SBRT as a Vaccination for Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain
- Status
- COMPLETED
- Phase
- PHASE2